A new screening assay for allosteric inhibitors of cSrc

Abstract

Targeting kinases outside the highly conserved ATP pocket is thought to be a promising strategy for overcoming bottlenecks in kinase inhibitor research, such as limited selectivity and drug resistance. Here we report the development and application of a direct binding assay to detect small molecules that stabilize the inactive conformation of the tyrosine kinase cSrc. Protein X-ray crystallography validated the assay results and confirmed an exclusively allosteric binding mode.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Figure 1: Schematic diagram of the fluorescent-labeled kinase assay for detecting allosteric inhibitors.
Figure 2: Screening of a compound library reveals pyrazoloureas binding to cSrc and p38α.
Figure 3: Crystal structures of cSrc in complex with type III inhibitors.

Accession codes

Accessions

Protein Data Bank

References

  1. 1

    Gschwind, A., Fischer, O.M. & Ullrich, A. Nat. Rev. Cancer 4, 361–370 (2004).

    CAS  Article  Google Scholar 

  2. 2

    Zhang, J., Yang, P.L. & Gray, N.S. Nat. Rev. Cancer 9, 28–39 (2009).

    Article  Google Scholar 

  3. 3

    Backes, A.C., Zech, B., Felber, B., Klebl, B. & Müller, G. Expert Opin. Drug Discovery 3, 1409–1425 (2008).

    CAS  Article  Google Scholar 

  4. 4

    Backes, A.C., Zech, B., Felber, B., Klebl, B. & Müller, G. Expert Opin. Drug Discovery 3, 1427–1449 (2008).

    CAS  Article  Google Scholar 

  5. 5

    Liu, Y. & Gray, N.S. Nat. Chem. Biol. 2, 358–364 (2006).

    CAS  Article  Google Scholar 

  6. 6

    Adrián, F.J. et al. Nat. Chem. Biol. 2, 95–102 (2006).

    Article  Google Scholar 

  7. 7

    Regan, J. et al. J. Med. Chem. 45, 2994–3008 (2002).

    CAS  Article  Google Scholar 

  8. 8

    Copeland, R.A., Pompliano, D.L. & Meek, T.D. Nat. Rev. Drug Discov. 5, 730–739 (2006).

    CAS  Article  Google Scholar 

  9. 9

    Wood, E.R. et al. Cancer Res. 64, 6652–6659 (2004).

    CAS  Article  Google Scholar 

  10. 10

    Daub, H., Specht, K. & Ullrich, A. Nat. Rev. Drug Discov. 3, 1001–1010 (2004).

    CAS  Article  Google Scholar 

  11. 11

    Annis, D.A., Nazef, N., Chuang, C.C., Scott, M.P. & Nash, H.M. J. Am. Chem. Soc. 126, 15495–15503 (2004).

    CAS  Article  Google Scholar 

  12. 12

    Jacobs, M.D., Caron, P.R. & Hare, B.J. Proteins 70, 1451–1460 (2008).

    CAS  Article  Google Scholar 

  13. 13

    Pargellis, C. et al. Nat. Struct. Biol. 9, 268–272 (2002).

    CAS  Article  Google Scholar 

  14. 14

    Yeatman, T.J. Nat. Rev. Cancer 4, 470–480 (2004).

    CAS  Article  Google Scholar 

  15. 15

    Michalczyk, A. et al. Bioorg. Med. Chem. 16, 3482–3488 (2008).

    CAS  Article  Google Scholar 

  16. 16

    Dar, A.C., Lopez, M.S. & Shokat, K.M. Chem. Biol. 15, 1015–1022 (2008).

    CAS  Article  Google Scholar 

  17. 17

    Seeliger, M.A. et al. Structure 15, 299–311 (2007).

    CAS  Article  Google Scholar 

  18. 18

    Dumas, J. et al. Bioorg. Med. Chem. Lett. 10, 2051–2054 (2000).

    CAS  Article  Google Scholar 

  19. 19

    Regan, J. et al. J. Med. Chem. 46, 4676–4686 (2003).

    CAS  Article  Google Scholar 

  20. 20

    Wan, P.T. et al. Cell 116, 855–867 (2004).

    CAS  Article  Google Scholar 

  21. 21

    Levinson, N.M. et al. PLoS Biol. 4, e144 (2006).

    Article  Google Scholar 

Download references

Acknowledgements

We thank the Dortmund Protein Facility for cloning, expressing and purifying the chicken cSrc and human p38α mutant variants for labeling. We thank M. Weyand, W. Blanckenfeldt, E. Hofmann, I. Vetter and beamline scientists at the Swiss Light Source of the Paul Scherrer Institute for expert assistance during data collection. We thank P. Janning for her assistance with the HPLC and MS analysis of the fluorescent-labeled and unlabeled cSrc, and we thank H. Waldmann and K. Shokat for helpful discussions. J.R.S. was funded by the Alexander von Humboldt Foundation. This work was supported by the German Federal Ministry for Education and Research through the German National Genome Research Network-Plus (NGFN-Plus) (grant number BMBF 01GS08102). Schering Plough, Bayer-Schering Pharma, Merck-Serono and Bayer CropScience are thanked for financial support.

Author information

Affiliations

Authors

Contributions

J.R.S. designed the p38α and cSrc constructs for labeling, developed the fluorescent-labeled kinase assay system and determined compound Kd, kon and koff values. S.K. overexpressed, purified and crystallized cSrc. C.G. determined the cocrystal structures. M.R. determined IC50 values. M.G. synthesized the compounds with assistance from S.K. and H.B.R. The manuscript was prepared by J.R.S. with assistance by all co-authors. D.R. designed the experiments.

Corresponding author

Correspondence to Daniel Rauh.

Supplementary information

Supplementary Text and Figures

Supplementary Figures 1–4, Supplementary Tables 1 and 2, and Supplementary Methods (PDF 874 kb)

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Simard, J., Klüter, S., Grütter, C. et al. A new screening assay for allosteric inhibitors of cSrc. Nat Chem Biol 5, 394–396 (2009). https://doi.org/10.1038/nchembio.162

Download citation

Further reading

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing